These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4227258)

  • 61. The dye test and complement-fixation test in toxoplasmosis; a comparative investigation.
    HULDT G
    Acta Pathol Microbiol Scand; 1958; 43(2):141-56. PubMed ID: 13544932
    [No Abstract]   [Full Text] [Related]  

  • 62. [Diagnostic value of the Sabin-Feldman and complement fixation tests in infection with Toxoplasma gondii].
    Barbarowski H; Zemburowa K; Laskownicka Z; Zaborski W; Gaszyńska A
    Wiad Parazytol; 1970; 16(2):223-34. PubMed ID: 5421617
    [No Abstract]   [Full Text] [Related]  

  • 63. [Use of a micromethod in complement deviation for the diagnosis of toxoplasmosis: comparative studies of 2 soluble antigens].
    Jannuzzi C; Campelli A; Mantero E
    Boll Ist Sieroter Milan; 1973; 52(3):237-41. PubMed ID: 4762780
    [No Abstract]   [Full Text] [Related]  

  • 64. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.
    Lennette EH; Schmidt NJ; Magoffin RL
    J Immunol; 1967 Oct; 99(4):785-93. PubMed ID: 4860926
    [No Abstract]   [Full Text] [Related]  

  • 65. [Results of a study of toxoplasmosis in persons with etiologically obscure diseases].
    Beregovaia LA; Iova NA; Ovcharenko PA; Netrebko ID
    Sov Med; 1967 Mar; 30(8):49-53. PubMed ID: 5629068
    [No Abstract]   [Full Text] [Related]  

  • 66. [Toxoplasmosis infection in clinical patient material].
    Sretenović M; Radojcić B; Ljaljević M; Scepan Lj; Leposavić V
    Med Pregl; 1966; 19(1):5-9. PubMed ID: 5946879
    [No Abstract]   [Full Text] [Related]  

  • 67. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis.
    Kodym P; Machala L; Rohácová H; Sirocká B; Malý M
    Clin Microbiol Infect; 2007 Jan; 13(1):40-7. PubMed ID: 17184286
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of a latex agglutination test for toxoplasmosis.
    Lunde MN; Jacobs L
    J Parasitol; 1967 Oct; 53(5):933-6. PubMed ID: 6062078
    [No Abstract]   [Full Text] [Related]  

  • 69. Preparation of toxoplasma antigen for use in the complement-fixation test.
    Morrissey LP; Ross WC
    Am J Med Technol; 1971 Jun; 37(6):230-2. PubMed ID: 5581736
    [No Abstract]   [Full Text] [Related]  

  • 70. [Immunologic, pneumoencephalographic and electroencephalographic studies in children with mental disorders after neonatal hemolytic disease].
    Kwiatkowska E
    Folia Med Cracov; 1967; 9(1):145-65. PubMed ID: 4963084
    [No Abstract]   [Full Text] [Related]  

  • 71. A survey of skin and complement fixation tests for toxoplasmosis in the Toronto area.
    HARPER DW; ORMSBY HL; COCKERAM A
    Can Med Assoc J; 1958 Jul; 79(1):25-8. PubMed ID: 13547022
    [No Abstract]   [Full Text] [Related]  

  • 72. [Serologic research on toxoplasmosis in pregnancy. Complement fixing antibodies in groups of healthy women and women with suspected infection due to Toxoplasma gondii].
    Cagliero L; Moro S
    Minerva Ginecol; 1965 Aug; 17(15):788-91. PubMed ID: 5846234
    [No Abstract]   [Full Text] [Related]  

  • 73. [Results of studies by means of the complement fixation test on toxoplasmosis in apes].
    UMINSKI J; PIETRZYK J
    World Wide Abstr Gen Med; 1961; 7(2)Suppl():411-2. PubMed ID: 13779156
    [No Abstract]   [Full Text] [Related]  

  • 74. [Use of the passive hemagglutination test for the serologic diagnosis of toxoplasma infection].
    Kvirikadze VV; Kogan RD
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):81-4. PubMed ID: 6005093
    [No Abstract]   [Full Text] [Related]  

  • 75. [Standardization of red cell suspensions for complement fixation and hemagglutination inhibition tests].
    Payzin S
    Mikrobiyol Bul; 1975 Oct; 9(4):343-7. PubMed ID: 1230640
    [No Abstract]   [Full Text] [Related]  

  • 76. [Scleroderma and diagnostic tests for toxoplasmosis].
    Dymowska Z; Mazurkiewicz W
    Przegl Dermatol; 1965; 52(6):607-12. PubMed ID: 5861456
    [No Abstract]   [Full Text] [Related]  

  • 77. [Modern methods used in the diagnosis of toxoplasmosis].
    Przybylkiewicz Z
    Wiad Parazytol; 1972; 18(2):165-72. PubMed ID: 4563911
    [No Abstract]   [Full Text] [Related]  

  • 78. [The diagnosis of toxoplasmosis].
    de Roever-Bonnet H; Hillenbrink HC
    Ned Tijdschr Geneeskd; 1966 Feb; 110(8):378-84. PubMed ID: 5905028
    [No Abstract]   [Full Text] [Related]  

  • 79. [Technic of collection of whole blood on filter paper in the serodiagnosis of human toxoplasmosis].
    Calderon C; Apt W; Melendez M; Sorensen R
    Rev Med Chil; 1973 Aug; 101(8):624-9. PubMed ID: 4775613
    [No Abstract]   [Full Text] [Related]  

  • 80. [Diagnostic value of the immunofluorescent method in toxoplasmosis].
    Samokhina LI
    Med Parazitol (Mosk); 1974; 43(6):669-72. PubMed ID: 4615259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.